Archeoptix Biomedical

ArcheOptix is advancing traumatic brain injury (TBI) care by bringing hospital-grade diagnostic precision to the point of care. Our patented NIRD® (Near‑Infrared Diffuse Reflectance) device is a lightweight, non-invasive scanner that detects acute subdural and epidural hematomas in under five minutes, with 95–98% accuracy and no radiation, gels, or shaving. Driven by our mission to improve brain health outcomes, our team blends deep expertise across neuroscience, biotech, and optics. We empower caregivers in ambulances, rural clinics, emergency departments, sports sidelines, and military settings with CT-level insight that supports faster triage, reduces unnecessary CT scans, cuts costs, and improves outcomes. Headquartered in Kingston, Ontario, ArcheOptix is Health Canada–approved, MDSAP–certified, and backed by a growing IP portfolio.